KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Cash from Investing Activities (2016 - 2025)

Cvs Health's Cash from Investing Activities history spans 17 years, with the latest figure at -$2.0 billion for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 265.27% year-over-year to -$2.0 billion, compared with a TTM value of -$5.9 billion through Dec 2025, up 22.88%, and an annual FY2025 reading of -$5.9 billion, up 22.88% over the prior year.
  • Cash from Investing Activities for Q4 2025 was -$2.0 billion at Cvs Health, up from -$2.1 billion in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$119.0 million in Q4 2022, with the low at -$10.4 billion in Q2 2023.
  • Average Cash from Investing Activities over 5 years is -$2.2 billion, with a median of -$1.5 billion recorded in 2021.
  • Year-over-year, Cash from Investing Activities surged 91.74% in 2022 and then plummeted 943.7% in 2023.
  • Tracing CVS's Cash from Investing Activities over 5 years: stood at -$1.4 billion in 2021, then surged by 91.74% to -$119.0 million in 2022, then plummeted by 943.7% to -$1.2 billion in 2023, then skyrocketed by 55.96% to -$547.0 million in 2024, then tumbled by 265.27% to -$2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Cash from Investing Activities are -$2.0 billion (Q4 2025), -$2.1 billion (Q3 2025), and -$1.0 billion (Q2 2025).